Ordenar

Buscar

01/07/2024 Evaluation of effective left ventricular pacing in cardiac resynchronization therapy
Zurita, FFM, Santos, JQ, Font, ER, Martin, CA, Ramos, JG, Garcia, BC, Weidmann, ZM, Bravo, EG, De Diego, IR, Martin, LS, Osorio, MG, Ramirez, DM, Jaen, EP, Nieves, AV, Prat, XV. Evaluation of effective left ventricular pacing in cardiac resynchronization therapy. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024 Ability of antigen carbohydrate 125 for diagnosis of heart failure with preserved ejection fraction
Baguda, JJD, Villota, JN, De la Espriella, R, De la Cal, TS, Vega, DG, Perez, PC, Carmena, MDGC, Minana, G, Sousa, I, Santas, E, Dolz, LM, Ferrer, MD, Gonzalez-Juanatey, JR, Martinez-Selles, M, Jimenez, JFD. Ability of antigen carbohydrate 125 for diagnosis of heart failure with preserved ejection fraction. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024 Rationale and design of a randomized double-blind trial to study the benefit of colchicine in patients with acutely decompensated heart failure: COLICA trial.
Villa, NF, Perez-Martinez, MT, Garcia-Garcia, AM, Nunez-Villota, J, Gonzalez-Juanatey, JR, Taibo-Urquia, M, Delgado-Jimenez, J, Bayes-Genis, A, Llacer-Iborra, P, Mirabet-Perez, S, Martinez-Selles, M, Anguita-Sanchez, M, Aimo, A, Sanchez-Fernandez, PL, Pascual-Figal, DA. Rationale and design of a randomized double-blind trial to study the benefit of colchicine in patients with acutely decompensated heart failure: COLICA trial.. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024 Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy
Fernandez, AAE, Otero, IG, Fernandez, SL, Santamarta, MR, Brugues, PF, Perez, FP, Corral, ES, Lopez, AL, Pinilla, JMG, Palomas, JLB, Bonet, LA, Marcos, MC, Mateo, VM, Benedicto, AM, Baguda, JD. Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024 Impact of preoperative left ventricular unloading on post-transplant outcomes of candidates bridged with venoarterial extracorporeal membrane oxygenation
Vazquez, DE, Barge-Caballero, E, Gonzalez-Vilchez, F, Almenar-Bonet, L, Garcia-Cosio, MD, Gonzalez-Costello, J, Gomez-Bueno, M, Castel-Lavilla, MA, Diaz-Molina, B, Martinez-Selles, M, Mirabet-Perez, S, De La Fuente-Galan, L, Hervas-Sotomayor, D, Rangel-Sousa, D, Crespo-Leiro, M. Impact of preoperative left ventricular unloading on post-transplant outcomes of candidates bridged with venoarterial extracorporeal membrane oxygenation. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024 Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes
Eppinger, S, Piayda, K, Galea, R, Sandri, M, Maarse, M, Güner, A, Karabay, CY, Pershad, A, Ding, WY, Aminian, A, Akin, I, Davtyan, KV, Chugunov, IA, Marijon, E, Rosseel, L, Schmidt, TR, Amabile, N, Korsholm, K, Lund, J, Guerios, E, Amat-Santos, IJ, Boccuzzi, G, Ellis, CR, Sabbag, A, Ebelt, H, Clapp, B, Assa, HV, Levi, A, Ledwoch, J, Lehmann, S, Lee, OH, Mark, G, Schell, W, della Rocca, DG, Natale, A, de Backer, O, Kefer, J, Esteban, PP, Abelson, M, Ram, P, Moceri, P, Osuna, JGG, Alvarez, XM, Cruz-Gonzalez, I, de Potter, T, Ghassan, M, Osadchiy, A, Chen, W, Goyal, SK, Giannini, F, Rivero-Ayerza, M, Afzal, S, Jung, C, Skurk, C, Langel, M, Spence, M, Merkulov, E, Lempereur, M, Shin, SY, Mesnier, J, Mckinney, HL, Schuler, BT, Armero, S, Gheorghe, L, Ancona, MBM, Santos, L, Mansourati, J, Nombela-Franco, L, Nappi, F, Kühne, M, Gaspardone, A, van der Pals, J, Montorfano, M, Fernández-Armenta, J, Harvey, JE, Rodés-Cabau, J, Klein, N, Sabir, SA, Kim, JS, Cook, S, Kornowski, R, Saraste, A, Nielsen-Kudsk, JE, Gupta, D, Boersma, L, Räber, L, Sievert, K, Sievert, H, Bertog, S. Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes. Cardiovascular Revascularization Medicine. 2024; 64DOI:10.1016/j.carrev.2024.02.014. PMID:38448258. IF:(Q/D).
01/07/2024 The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment
Ramos-Regalado, L, Alcover, S, Badimon, L, Vilahur, G. The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment. Cells. 2024; 13(13)DOI:10.3390/cells13131125. PMID:38994977. IF:5.200(Q2/3D).
01/07/2024 Temporal trends in ICD prescription as primary prevention in non ischemic cardiomyopathy: 10 year single center registry
Crehuet, A, Abos, CM, Corcoy, MSI, Donlo, JM, Garcia, BC, Iniesta, MS, Ramon, CS, Benedicto, AM, Varo, AP, Ferrer, MD, Crespo, MC. Temporal trends in ICD prescription as primary prevention in non ischemic cardiomyopathy: 10 year single center registry. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).